What sports and exercise restrictions apply during infectious mononucleosis, and when is it safe to resume contact and high‑intensity activities?

Sports and Exercise Restrictions During Infectious Mononucleosis

Athletes with infectious mononucleosis should avoid all contact sports and strenuous exercise for at least 3 weeks from symptom onset, with return to play decisions guided by clinical resolution and consideration of splenic status through 4 weeks. 1, 2

Immediate Activity Restrictions

• Complete restriction from contact sports and high-intensity activities must begin at diagnosis and continue for a minimum of 3 weeks from symptom onset. 1, 2
• Light aerobic activity (walking, stationary cycling at <70% maximum heart rate) may be permitted once fever resolves and the athlete feels well enough, but no resistance training or sport-specific drills during the acute phase. 3
• Athletes should maintain activity reduction and bed rest as tolerated throughout the symptomatic period. 4

The Splenic Rupture Risk Window

The most critical concern is spontaneous splenic rupture, which occurs in 0.1-0.5% of mononucleosis cases and is potentially fatal. 4, 5

Key timing data:

• Only 73.8% of splenic ruptures occur within the traditional 21-day restriction period. 5
• 90.5% of splenic injuries occur within 31 days of symptom onset, suggesting the risk window extends beyond current standard recommendations. 5
• Mean time to splenic injury is 15.4 days (±13.5 days), with substantial injuries occurring between days 21-31. 5

Return to Play Algorithm

Week 1-3 (Days 1-21):

• Absolute restriction from all contact sports, collision activities, and high-intensity exercise. 1, 2
• No wrestling, boxing, football, rugby, hockey, basketball, soccer, or similar contact sports. 6
• Light walking only if fever-free and energy permits. 3

Week 4 (Days 22-28):

• Consider extending complete restriction through day 31 given that 26.2% of splenic ruptures occur after day 21. 5
• If return is contemplated at 3 weeks, shared decision-making should incorporate discussion of residual rupture risk. 2
• Serial ultrasonography at 4 weeks can inform return decisions: 84% of athletes show normal splenic dimensions by 1 month, allowing safer return. 7

Week 5+ (Day 29 onward):

• Graduated return to activity may begin if: fever resolved, pharyngitis resolved, no palpable splenomegaly on exam, and patient feels well. 4, 1
• If splenomegaly persists on ultrasound at 4 weeks, repeat imaging at 8 weeks before clearing for contact sports. 7
• Follow stepwise progression: light aerobic activity → sport-specific drills without contact → non-contact practice → full-contact practice → competition. 8

Clinical Clearance Criteria

Before returning to contact sports, athletes must demonstrate:

• Complete resolution of fever, pharyngitis, and systemic symptoms. 4, 1
• No palpable splenomegaly on physical examination. 4
• Normal energy levels and absence of profound fatigue. 4
• Laboratory markers (if checked) showing resolution: normalized transaminases and declining atypical lymphocytosis. 1, 2

Imaging Considerations

• Routine ultrasound at 1 month post-diagnosis allows objective assessment of splenic size and can facilitate earlier, safer return to contact sports. 7, 2
• 16% of athletes will still have splenomegaly at 4 weeks and require extended restriction. 7
• All athletes with persistent splenomegaly at 4 weeks should undergo repeat ultrasound at 8 weeks before contact sport clearance. 7

Common Pitfalls to Avoid

Do not:

• Allow return to contact sports before 3 weeks regardless of how well the athlete feels—asymptomatic athletes remain at rupture risk. 5, 2
• Rely solely on physical examination to rule out splenomegaly—palpation has limited sensitivity, and ultrasound provides objective data. 7, 2
• Assume the 21-day window is absolute protection—nearly one-quarter of ruptures occur after this timeframe. 5
• Prescribe corticosteroids routinely—they are not recommended for uncomplicated mononucleosis and may mask symptoms. 1, 2
• Use antibiotics like amoxicillin or ampicillin, which cause rash in 90% of mononucleosis patients. 4

Special Populations

Immunosuppressed athletes:

• Face higher risk of severe disease and significant morbidity. 1
• Require more conservative return-to-play timelines and closer monitoring. 1

Athletes with complications:

• Those with hepatomegaly, elevated liver enzymes >3x normal, or other organ involvement require individualized assessment beyond standard timelines. 4, 1
• Chronic fatigue syndrome develops in a subset of patients and may prolong recovery beyond typical timeframes. 4

Conservative Recommendation for High-Risk Scenarios

For collision sports (wrestling, boxing, rugby, football) or athletes with documented splenomegaly, extend restriction to 4 weeks minimum with ultrasound confirmation of normal splenic size before clearance. 5, 7 This approach accounts for the 90.5% capture of rupture events within 31 days and provides objective imaging data rather than relying on clinical examination alone. 5, 7